Lantheus Medical Imaging

Lantheus Medical Imaging

MA - Bedford
Biotechnology3 H-1B visas (FY2023)

Focus: Small Molecules for Imaging

Lantheus Medical Imaging is a life sciences company focused on Small Molecules for Imaging.

OncologyCardiovascularNephrologyMetabolic DiseasesRespiratory
Funding Stage
PUBLIC
Open Jobs
1

Products & Portfolio (2)

4 discontinued products not shown

Pipeline & Clinical Trials

Contrast enhanced pituitary magnetic resonance imaging
Pituitary Adenoma
N/A
Clinical Trials (1)
NCT07335315Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
N/A
Contrast Specific Echocardiogram Versus Left Ventricular Opacification (LVO) Imaging Settings
Contrast Echocardiography Imaging
N/A
Clinical Trials (1)
NCT04286100Contrast Specific Echocardiogram Versus Left Ventricular Opacification (LVO) Imaging Settings
N/A
Carotid Contrast Enhanced Ultrasound
Atherosclerosis
N/A
Clinical Trials (1)
NCT05416385Carotid Intraplaque Neovascularization Combined With Stress Echo
N/A
N/A
Clinical Trials (1)
NCT05712473An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer
N/A
Clinical Trials (1)
NCT01085162A Long-term Follow-up Study to Evaluate the Predictive Value of BMS747158 in Patients Suspected of Coronary Artery Disease (CAD)
N/A
Can Ultrasound Replace Computed Tomography (CT) Scan in Those Unable to Have Computed Tomography (CT
Nephrotoxicity of CT Contrast Agents
N/A
Clinical Trials (1)
NCT01151566Can Ultrasound Replace Computed Tomography (CT) Scan in Those Unable to Have Computed Tomography (CT) Contrast Agents
N/A
Early Detection of Broken Hearts in Cancer Patients
Cardiotoxicity
N/A
Clinical Trials (1)
NCT02086695Early Detection of Broken Hearts in Cancer Patients
N/A
Total-body PET imaging
Prostate Cancer
N/A
Clinical Trials (1)
NCT05160480A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
N/A
Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
Coronary Artery Disease
N/A
Clinical Trials (1)
NCT01436773Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
N/A
Gadofosveset Triodium
Pulmonary Embolism
N/A
Clinical Trials (1)
NCT01165892Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar)
N/A
Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocar
Thrombus
N/A
Clinical Trials (1)
NCT00539045Diagnostic Utility of Contrast Echocardiography for Detection of LV Thrombi Post ST Elevation Myocardial Infarction
N/A
Retrospective Safety Study to Compare Mortality in Intensive Care Unite (ICU) Patients Undergoing Ec
Cardiovascular Disease
N/A
Clinical Trials (1)
NCT01299649Retrospective Safety Study to Compare Mortality in Intensive Care Unite (ICU) Patients Undergoing Echocardiography With or Without DEFINITY®
N/A
bicycle stress echocardiography
Mitral Annulus Calcification
N/A
Clinical Trials (1)
NCT04093973Bicycle Exercise Echocardiography to Assess Physiological Significance of Mitral Annular Calcification
N/A
Glucagon-Like-Peptide-1/Regadenoson/Perflutren Lipid Microsphere
Coronary Artery Disease
N/A
PET scan quantifying sympathetic denervation using [18F]-LMI1195
Sudden Cardiac Arrest
N/A
Clinical Trials (1)
NCT03493516Prediction of ARrhythmic Events With Positron Emission Tomography II
N/A
Echocardiography: Value and Accuracy at REst and STress
Coronary Artery Disease
N/A
Clinical Trials (1)
NCT03674255Echocardiography: Value and Accuracy at REst and STress
N/A
Clinical Trials (1)
NCT01135316Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR
N/A
Ultrasound
Atheroma
N/A
Clinical Trials (1)
NCT03466255Early Detection of Cardiovascular Disease
N/A
gadofosveset
Healthy
N/A
Clinical Trials (1)
NCT01431300Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy Participants
N/A
Definity
Endoleaks
N/A
Clinical Trials (1)
NCT01005212Evaluation of Contrast-Enhanced Ultrasound to Detect Endoleaks After Endovascular Aortic Aneurysm Repair
N/A
Phase 1
Clinical Trials (1)
NCT00707538A Phase I Study in Healthy Volunteers to Assess Dosimetry and Safety Following Injection of BMS747158 at Stress
Phase 1
Phase 1
Clinical Trials (1)
NCT00930631Study of [3H] BMS747158 in Healthy Male Subjects
Phase 1
LMI 1195-101
Heart Failure
Phase 1
Clinical Trials (1)
NCT00891241A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure
Phase 1
Perflutren Lipid Microspheres
Adnexal Mass
Phase 1
Clinical Trials (1)
NCT03297112Contrast-Enhanced Subharmonic Ultrasound Imaging in Improving Characterization of Adnexal Masses in Patients Undergoing Surgery
Phase 1
Piflufolastat F18
Pancreatic Cancer
Phase 1
Clinical Trials (1)
NCT05394259A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
Phase 1
BMS747158
Healthy
Phase 1
Clinical Trials (1)
NCT00707499A Phase I Study in Healthy Volunteers to Assess Safety of BMS747158
Phase 1
Technetium Tc99m Sestamibi
Kawasaki Disease
Phase 1/2
Clinical Trials (1)
NCT00162045A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects
Phase 1/2
N-acetylcysteine
Aging
Phase 1/2
Clinical Trials (1)
NCT01384591Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT07357519Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)
Phase 1/2
Phase 1/2
64Cu-LNTH-1363S
Metastatic Sarcoma
Phase 1/2
Clinical Trials (1)
NCT0629891664Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Phase 1/2
BMS747158
Ischemia
Phase 2
Clinical Trials (1)
NCT00849108Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158
Phase 2
Phase 2
Clinical Trials (1)
NCT01062178Efficacy of Ultrasound Contrast Agent to Assess Renal Masses
Phase 2
Peflutren Lipid Microsphere Injectable Suspension
Liver Disease
Phase 2
Clinical Trials (1)
NCT00162058A Phase II Study of DMP 115 to Assess Focal Liver Lesions
Phase 2
Perflutren lipid microsphere
Von-Hippel Lindau
Phase 2
Clinical Trials (1)
NCT03907657Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau
Phase 2
Perflutren Lipid microsphere
Chronic Kidney Diseases
Phase 2
Clinical Trials (1)
NCT03196076Contrast-enhanced Ultrasound for Complex Kidney Lesion Diagnosis in Patients With CKD Extension
Phase 2
Phase 2
Clinical Trials (1)
NCT01085175Trial to Determine Imaging Parameters of LMI1195 in Heart Failure Patients at Low and High Risk of Defibrillator Firing
Phase 2
Clinical Trials (1)
NCT03243942Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement
Phase 2
Phase 2
Clinical Trials (1)
NCT05820724PSMA PET Scan and mpMRI for Prostate Cancer Detection
Phase 2
Clinical Trials (1)
NCT05247541Diagnosing Compartment Syndrome With SHAPE vs Elastography
Phase 2/3
Phase 2/3
Clinical Trials (1)
NCT07084909Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCC
Phase 2/3
DEFINITY®
Cardiac Disease
Phase 3
Clinical Trials (1)
NCT03719612DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
Phase 3
Phase 3
Clinical Trials (1)
NCT01681524Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI
Phase 3
Phase 3
Clinical Trials (1)
NCT03571672DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
Phase 3
Ultrasound contrast agent
Hepatocellular Carcinoma
Phase 3
Clinical Trials (1)
NCT02764801Contrast-enhanced Ultrasound Evaluation of Chemoembolization
Phase 3
Phase 3
Clinical Trials (1)
NCT01347710A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
Phase 3
Phase 3
Clinical Trials (1)
NCT00162032A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki Disease
Phase 3
PSMA PET/CT guided intensification of therapy
Prostate Cancer
Phase 3
Clinical Trials (1)
NCT04557501PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer
Phase 3
Phase 4
Clinical Trials (1)
NCT00401687DMP115 in Patients With an Ejection Fraction Between 25%-40% to Evaluate the Use of Contrast Echocardiography to Assess Heart Function
Phase 4

Open Jobs (1)

Interview Prep Quick Facts
Portfolio: 6 approved products, 47 clinical trials
H-1B (2023): 3 approvals
Open Roles: 1 active job
Portfolio Health
Peak2 (33%)
LOE Approaching4 (67%)
6 total products

Hiring Trend

Stable
1
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
3
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub